Craft
  • Home
  •  / Spark Therapeutics
Spark Therapeutics

Spark Therapeutics

Patents and Patent Applications

297

FY, 2016

Revenue

$64.7 M

FY, 2018

Market Capitalization

$4.4 B

2019-12-17

Spark Therapeutics Summary

Company summary

Overview
Spark Therapeutics is a gene therapy company. The Company focuses on treating orphan diseases. It has a pipeline of product candidates targeting multiple rare blinding conditions, hematologic disorders and neurodegenerative diseases.
Type
Public
Founded
2013
HQ
Philadelphia, PA, US | view all locations
Website
http://sparktx.com
Cybersecurity rating
ESG rating
out of 100 | View all ESG data
Sectors

Key people

  • Jeffrey D. Marrazzo

    Jeffrey D. Marrazzo, Chief Executive Officer, Co-Founder

  • Lars Ekman, Director

    • Katherine A. High

      Katherine A. High, President and Head of Research and Development

      • Stephen Webster, Chief Financial Officer

        Operating MetricsView all

        Patents and Patent Applications

        297

        FY, 2016

        LocationsView all

        1 location detected

        • Philadelphia, PA HQ

          United States

          3737 Market St

        Spark Therapeutics Financials

        Summary financials

        Revenue (Q3, 2019)
        $22.4M
        Net income (Q3, 2019)
        ($66.6M)
        Cash (Q3, 2019)
        $207.1M
        EBIT (Q3, 2019)
        ($68.7M)
        Enterprise value
        $4.2B

        Footer menu